This page has been fact-checked by a Doctor of nursing practice specializing in Oncology and has experience working with mesothelioma patients.
Sources of information are listed at the bottom of the article. We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Localized mesothelioma occurs when it is relatively small and confined to the tissue, organ, or part of the body in which it originated. Most cases of mesothelioma are diffuse, the opposite of localized. The localized type is rare, but the prognosis is better.
Localized vs Diffuse Mesothelioma – What’s the Difference?
There are several ways to classify mesothelioma. One of the most common is by location of initial tumor growth. The three main types of mesothelioma are pleural, peritoneal, and pericardial. Experts also organize the disease into three types by cell: epithelial, sarcomatoid, and biphasic.
Mesothelioma can also be classified by the extent of the cancerous growth. Most diagnosed mesothelioma cases are diffuse, but in rare cases, the tumors may be considered localized. Localized mesothelioma is confined to one small area.
- The vast majority of diagnosed cases of mesothelioma are diffuse, meaning the tumors that form are small, multiple, and spread out over a significant area of tissue, organs, or multiple parts of the body.
- A review of the literature from 2019 found just 101 reported cases of localized malignant mesothelioma in English journals.
- Localized tumors are fewer in number and have well-defined boundaries. They tend to be localized to one area of one organ or part of the body.
- These cases remain consistent with other cases of mesothelioma, generally male patients and originating in the pleural space.
- The pathology subtype is usually epitheloid. However, there are cases of the more aggressive sarcomatoid mesothelioma, or biphasic where there is a mix of both types of cells.
- The histological features, or characteristics of the cells, are usually identical between diffuse and localized types.
- Patients diagnosed with localized mesothelioma have a better prognosis than those diagnosed with diffuse mesothelioma.
- Treatment strategies may allow for a more aggressive surgical approach, thus removing the entire area of cancer entirely.
What Are the Symptoms of Localized Mesothelioma?
The symptoms of localized mesothelioma reflect the area of growth. Patients with pleural tumors usually experience difficulty breathing, a persistent cough, and chest pains.
When the tumors grow in the peritoneum, they cause abdominal swelling and pain and often gastrointestinal symptoms like constipation.
The symptoms of localized mesothelioma are less widespread than those of diffuse mesothelioma.
Diagnosing Localized Malignant Mesothelioma
The diagnostic procedure is similar for any type of mesothelioma, beginning with a physical exam and routine tests to rule out other causes of symptoms.
If a doctor suspects cancer, they will order imaging scans to look for unusual areas of tissue. They will then do a biopsy to remove tissue from a suspected site of malignancy.
Pathologists look at those cells under a microscope to determine if they are benign or malignant. If they are malignant, they describe the cell type and any characteristics that help make a diagnosis. The features at the cellular level are identical for localized and diffuse mesothelioma, which can lead to confusion.
Misdiagnoses for Localized Mesothelioma
The more prominent features of the tumors are significantly different, which helps distinguish between the two diffuse and localized mesothelioma. However, because localized mesothelioma is so rare, it may be misdiagnosed as another type of cancer altogether.
For example, in one case study, a patient received a diagnosis of a benign localized fibrous tumor that turned out to be localized mesothelioma. She had no previous exposure to asbestos and had no symptoms until months later, when typical mesothelioma symptoms began. By then, the cancer had grown, and she received the correct diagnosis.
Treating Localized Mesothelioma
For most cases of mesothelioma, treatment involves a multi-modal approach, utilizing chemotherapy, surgery, and radiation therapy in addition to any emerging treatments that may help, such as immunotherapy.
A major roadblock in treating diffuse mesothelioma is the nature of the tumors. Because they spread out so far, surgery is often not indicated. With localized mesothelioma, however, surgery is more likely to be successful.
In most cases of localized malignant mesothelioma, the patient will undergo aggressive surgery to remove the tumors. This is usually paired with chemotherapy or radiation to reduce further the risk of microscopic cells not being removed at the time of surgery.
This decreases the chances these cells will form new tumors and spread to other parts of the body. Doctors often recommend aggressive treatment because it may be curable for localized tumors.
What Is the Prognosis for Localized Malignant Mesothelioma?
The prognosis for localized mesothelioma is generally much better than for diffuse mesothelioma. Localized tumors are easier to remove with surgery, resulting in a better prognosis and a longer life expectancy. However, because localized mesothelioma is rare and studies of it limited, accurate survival times or prognosis estimations are limited.
One study reviewed the literature but found it difficult to come up with a good average or median survival time. Some studies indicated a median survival of 12 to 36 months, while others reported median survival times of up to 29 months.
What was clear from these studies was that survival time is longer and prognosis significantly more favorable for a diagnosis of localized as compared to diffuse mesothelioma.
Localized malignant mesothelioma is rare, but it does occur, both with and without known asbestos exposure. How it will progress is not always certain, but patients with this type of mesothelioma have a better chance of survival after aggressive surgery. Getting an accurate diagnosis as early as possible is essential.Get Your FREE Mesothelioma Packet
Page Written by Mary Ellen Ellis
Mary Ellen Ellis has been the head writer for Mesothelioma.net since 2016. With hundreds of mesothelioma and asbestos articles to her credit, she is one of the most experienced writers on these topics. Her degrees and background in science and education help her explain complicated medical topics for a wider audience. Mary Ellen takes pride in providing her readers with the critical information they need following a diagnosis of an asbestos-related illness.
Page Medically Reviewed and Edited by Anne Courtney, AOCNP, DNP
Anne Courtney has a Doctor of Nursing Practice degree and is an Advanced Oncology Certified Nurse Practitioner. She has years of oncology experience working with patients with malignant mesothelioma, as well as other types of cancer. Dr. Courtney currently works at University of Texas LIVESTRONG Cancer Institutes.